Addison's Disease Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Cardiovascular Disease Incidence and Cardiovascular Health Among Diverse Women With Breast and Gynecologic Cancers
Oncol Nurs Forum. 2024 Feb 19;51(2):113-125. doi: 10.1188/24.ONF.113-125.ABSTRACTOBJECTIVES: To examine if racial differences in cardiovascular health (CVH) are associated with cardiovascular disease (CVD) disparities among women with breast and gynecologic cancers.SAMPLE & SETTING: The sample consisted of 252 Black women and 93 White women without a self-reported history of cancer or CVD who developed a breast or gynecologic malignancy. Women who developed CVD before their cancer diagnosis were excluded.METHODS & VARIABLES: CVH was classified using metrics of the American Heart Association's Life's Simple 7 framew...
Source: Oncology Nursing Forum - March 5, 2024 Category: Nursing Authors: Timiya S Nolan Jennifer A Sinnott Jessica L Krok-Schoen Elizabeth K Arthur Emily Ridgway-Limle Darrell M Gray Ii Daniel Addison Sakima Smith Karen Patricia Williams Darryl B Hood Joshua J Joseph Ashley Felix Source Type: research

Clinical characteristics and predictive factors of delayed diagnosis in patients with sellar germ cell tumors
ConclusionIn patients with sellar GCTs, delayed diagnosis is common and linked to increased pituitary dysfunction. The initial symptoms of slow growth, polyuria/polydipsia, and amenorrhea, as well as germinoma with negative tumor markers, predict the possibility of a delayed diagnosis. Early diagnosis is crucial to minimize the impact of sellar GCTs on pituitary function. (Source: Journal of Neuro-Oncology)
Source: Journal of Neuro-Oncology - March 4, 2024 Category: Cancer & Oncology Source Type: research

Cytokine Release Syndrome with Relative Adrenal Insufficiency Induced by Ipilimumab and Nivolumab Combination Therapy for Clear Cell Renal Cell Carcinoma
Intern Med. 2024 Mar 4. doi: 10.2169/internalmedicine.3115-23. Online ahead of print.ABSTRACTCombination therapy with ipilimumab and nivolumab is indicated for many types of cancers; however, several patients experience immune-related adverse events (irAEs). We herein report a case of cytokine release syndrome (CRS) in a 63-year-old woman with stage IV left clear cell renal cell carcinoma. Our patient developed CRS while taking prednisolone, 43 days after the start of ipilimumab and nivolumab administration. The patient was treated with steroid pulse therapy, which improved the symptoms of shock and respiratory failure. In...
Source: Internal Medicine - March 3, 2024 Category: Internal Medicine Authors: Kohei Yamamoto Shinsuke Shiotsu Misaki Sasakura Shunya Tanaka Shiho Goda Taisuke Tsuji Tatsuya Yuba Chieko Takumi Noriya Hiraoka Source Type: research